Yahoo Web Search

Search results

1. sotio.com › about-us › the-companyThe Company | Sotio

   sotio.com › about-us › the-company

   • Cached

   SOTIO Biotech is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. Our robust pipeline includes a next-generation PD-1-inhibiting cytokine, a proprietary technology designed to improve on the efficacy of CAR T therapies and a new generation of potent and stable antibody-drug conjugates (ADCs).

   • PPF Group

     PPF Group - The Company | Sotio

   • The Company

     The Company - The Company | Sotio

   • Clinical Trials

     Clinical Trials - The Company | Sotio

   • Career

     Career - The Company | Sotio

   • Contacts

     SOTIO Biotech B.V. Strawinskylaan 933 1077XX Amsterdam...

   • Science

     Science - The Company | Sotio

   • Pipeline

     Pipeline - The Company | Sotio

   • News & Publications

     SOTIO Biotech, a clinical-stage immuno-oncology company...

2. thehealthcaretechnologyreport.com › the-top-25The Top 25 Biotech Executives of 2024 | The Healthcare ...

   thehealthcaretechnologyreport.com › the-top-25

   • Cached

   May 7, 2024 · Ying Huang currently serves as Chief Executive Officer of Legend Biotech, a global biotechnology company focused on developing, manufacturing, and commercializing life-saving therapies. As CEO, Huang supports the company’s mission to reimagine healthcare and deliver transformative treatments through cell therapy.

3. www.fiercebiotech.com › biotech › little-europeanLittle European biotech Sotio nabs a super $316M funding ...

   www.fiercebiotech.com › biotech › little-european

   • Cached

   Dec 3, 2021 · “We are very excited and grateful for the continued strong support we’ve received from PPF Group today and since our inception,” said Radek Spisek, Ph.D., CEO of Sotio.

4. en.wikipedia.org › wiki › SotioSotio - Wikipedia

   en.wikipedia.org › wiki › Sotio

   • Cached

   The CEO of the company is Radek Špíšek, who has been with the company since its beginning, initially functioning as Chief Scientific Officer. [ 5] Operations. SOTIO conducts global operations in Europe, the USA, and China. In January 2020, the company announced the founding of its subsidiary SOTIO Biotech AG in Basel, Switzerland. [ 6] .

5. www.ppf.eu › en › our-companiesPPF Group | Sotio

   www.ppf.eu › en › our-companies

   • Cached

   SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, announced today that is has secured €280m of funding to significantly expand and advance its clinical pipeline, including its lead asset SOT101, an IL-15 superagonist, and three new clinical programs until end of 2023.

6. talkmarkets.com › content › avoid-these-pitfalls-ofAvoid These Pitfalls Of Biotech Investing | TalkMarkets

   talkmarkets.com › content › avoid-these-pitfalls-of

   • Cached

   19 hours ago · Avoid These Pitfalls Of Biotech Investing. By Marc Lichtenfeld of Wealthy Retirement. Friday, August 30, 2024 8:30 PM EDT. Image Source: Unsplash. “It’s either water, or it’s not water. And we know it’s not water.”. That’s what the CEO of a small cap biotech company once said to me in a hotel suite during the J.P. Morgan Healthcare ...

7. People also ask

   Who is the CEO of Soto Biotech?

   • The CEO of SOTIO is Radek Špíšek. He has been with the company since its beginning, initially functioning as Chief Scientific Officer. SOTIO conducts global operations in Europe, the USA, and China. In January 2020, the company announced the founding of its subsidiary SOTIO Biotech AG in Basel, Switzerland.

   Sotio - Wikipedia

   en.wikipedia.org/wiki/sotio

   See all results for this question

   Is Soto a safe & effective treatment for solid tumours?

   • SOTIO validates the safety and efficacy of its products in comprehensive clinical trials conducted in Europe and the US since 2012. In October 2023, SOTIO signed a licence and option agreement with Dutch company Synaffix to develop next-generation ADCs for the treatment of solid tumours.

   PPF Group | Sotio

   www.ppf.eu/en/our-companies/sotio

   See all results for this question

   What does Sotio do with Cytune Pharma?

   • In August 2018, SOTIO acquired Cytune Pharma and announced the continued development of the company's lead program SO-C101 (RLI-15) which is a human fusion protein of IL-15 and the high-affinity binding domain of IL-15Ra.

   Sotio - Wikipedia

   en.wikipedia.org/wiki/sotio

   See all results for this question

   Who is the new CEO of Vir Biotechnology?

   • Sung Lee is now CFO and Jeffrey Calcagno became chief business officer. Vir is still looking for a replacement for Pang. Vir Biotechnology conducted a worldwide search to find the perfect CEO. In the end, the board picked Bayer’s Marianne de Backer.

   How Vir found the one: CEO Marianne De Backer

   www.fiercebiotech.com/biotech/how-vir-found-one-ceo-marianne-de-backer

   See all results for this question

8. www.fiercebiotech.com › biotech › how-vir-found-oneHow Vir found the one: CEO Marianne De Backer - Fierce Biotech

   www.fiercebiotech.com › biotech › how-vir-found-one

   • Cached

   Apr 19, 2024 · Vir Biotechnology conducted a worldwide search to find the perfect CEO. In the end, the board picked Bayer’s Marianne De Backer, Ph.D., because of her three decades of experience in the...